𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis B vaccination campaign in a low endemicity area

✍ Scribed by Grob, P. J. ;Rickenbach, M. ;Steffen, R. ;Wagner, S. ;Kistler, G. ;Schmid, M. ;Gutzwiller, F.

Publisher
Springer-Verlag
Year
1985
Weight
288 KB
Volume
4
Category
Article
ISSN
0722-2211

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pediatric fulminant hepatic failure in e
Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination
✍ Huey-Ling Chen; Chee-Jen Chang; Man-Shan Kong; Fu-Chen Huang; Hung-Chang Lee; Ch πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

To investigate the role of hepatitis B virus (HBV) infection in pediatric fulminant hepatic failure (FHF) after the launch of universal HBV vaccination, the authors analyzed the data from patients with FHF collected from a nationwide collaborative study group. Children aged 1 month to 15 years who w

A pilot model of vaccination against hep
A pilot model of vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas
✍ Prof. G. da Villa; M. Piazza; R. Lorio; L. Picciotto; P. Peluso; G. Deluca; B. B πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 407 KB

## Abstract A hepatitis B vaccination campaign was carried out in a town of 60,000 inhabitants, Afragola, Campania, Italy, a hyperendemic area for hepatitis B where HBsAg prevalence was 13.4% and anti‐HBc prevalence was 64.7%. This experimental pilot project aimed to reduce the incidence of both ac

Prevalence of isolated antibody to hepat
Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implications in hepatitis B vaccination programs
✍ Anna S. F. Lok; Ching-Lung Lai; Pui-Chee Wu πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 622 KB

Of 1,801 Chinese subjects, age 1 to 90 years, screened for hepatitis B surface antigen and antibody (HBsAg, anti-HBs) and antibody to hepatitis B core antigen (anti-HBc), 214 (1 1.9%) had an isolated, positive anti-HBc result; anti-HBc was reproducibly present in the initial sera in only 66% and per

Hepatitis B vaccine in infants from an e
Hepatitis B vaccine in infants from an endemic area: Long-term anti-HBs persistence and revaccination
✍ B. Yvonnet; P. Coursaget; J. Chotard; M. Sarr; R. Ndoye; J. P. Chiron; I. Diop-M πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 395 KB

Persistence of anti-HBs in 156 Senegalese infants immunized with hepatitis B vaccine was studied for periods ranging from 2 to 6 years after booster dose administration. Six years after the booster dose, 90.4% of the infants had detectable anti-HBs antibodies, with 78.1% having titers higher than 10